Analyst Ratings — October 18, 2026 — Weekend Recap — Last 48 Hours (Pacific Time)

Executive Summary

The weekend recap covers 175 analyst actions dominated by reiterations and initiations, with a meaningful wave of price target cuts — particularly in financials, transport, and select tech names — tempering an otherwise constructive tone. AI-driven optimism powered notable raises for Microsoft, SpaceX, Twilio, and ServiceNow, while the Varonis acquisition by Proofpoint/Thoma Bravo triggered one of the broadest coordinated downgrades of the period. William Blair was the most active firm with a sweeping biotech initiation blitz, while StoneX, D.A. Davidson, and H.C. Wainwright also logged heavy activity.

Analyst Action Breakdown

Net Sentiment: Mixed — leaning Cautiously Bullish
Initiations were overwhelmingly bullish (most at Outperform/Buy). However, downgrades slightly outnumber upgrades, and PT cuts match PT raises in volume. The bullish lean is driven by initiation activity and AI-themed raises rather than broad-based conviction shifts.

Top Analyst Calls

🟢 StoneX → Microsoft (MSFT) — PT Raised to $600 from $450, maintains Buy

• Rationale: Firm cites meaningful AI progress as justification for a $150 (33%) price target increase — the largest magnitude raise of the period.

🟢 Evercore ISI → SpaceX (SPCX) — PT Raised to $275 from $230, maintains Outperform

• Rationale: Compute growth drives the upgrade in price target for the high-profile space and technology company.

🟢 BTIG → Twilio (TWLO) — PT Raised to $315 from $285, maintains Buy

• Rationale: AI agent opportunity seen as a significant growth catalyst for the communications platform.

🟢 Piper Sandler → ServiceNow (NOW) — PT Raised to $175 from $140, maintains Overweight

• Rationale: AI-driven growth underpins a 25% price target increase for the enterprise software giant.

🟢 Truist → Bloom Energy (BE) — PT Raised to $240 from $218, maintains Buy

• Rationale: Demand growth supports the bullish outlook on the clean energy company.

🟢 Cantor Fitzgerald → Strategy (MSTR) — PT Raised to $208 from $186, maintains Overweight

• Rationale: Bitcoin gains drive the price target increase on the bitcoin-focused company.

🟢 Raymond James → Capri Holdings (CPRI) — Upgraded to Strong Buy from Outperform

• Rationale: Favorable turnaround progress cited as the basis for the upgrade of the luxury fashion group.

🟢 DA Davidson → Martin Marietta Materials (MLM) — Upgraded to Buy from Neutral

• Rationale: Firm sets a new Buy rating on the construction materials company.

🟢 Tigress Financial → Costco (COST) — PT Raised to $1,250 from $1,065, maintains Buy

• Rationale: Membership growth drives a significant $185 price target increase.

🔴 Bernstein SocGen → Skydance (SKYD) — PT Cut to $6 from $12, maintains rating

• Rationale: Execution risk prompts a 50% price target reduction — the steepest percentage cut of the period.

🔴 Jefferies → FMC Corp. (FMC) — Downgraded to Hold from Buy, PT Cut to $5 from $14

• Rationale: A pricing model shift drives both a downgrade and a dramatic 64% price target cut.

🔴 VRNS Consensus Shift → Varonis Systems (VRNS) — Downgraded by 6 firms simultaneously

• Rationale: The Proofpoint/Thoma Bravo acquisition triggered coordinated downgrades from TD Cowen, Needham, DA Davidson, RBC Capital, Jefferies, Piper Sandler, and Rosenblatt — all moving to Hold/Neutral with targets near $49.75.

🔴 Citizens → Rocket Lab (RKLB) — PT Cut to $90 from $130, maintains Market Outperform

• Rationale: Neutron rocket delay to 2027 prompts a sharp $40 price target reduction.

🔴 UBS → WillScot (WSC) — PT Cut to $18 from $29, maintains Neutral

• Rationale: Margin concerns drive a significant 38% price target reduction.

🔴 JPMorgan → Eastman Chemical (EMN) — Downgraded to Neutral from Overweight, PT Cut to $66

• Rationale: Commodity spread pressures drive both the downgrade and target reduction.

Firm Activity Summary

William Blair — 12 calls (12 bullish, 0 bearish)

• Initiated Outperform on: Tango Therapeutics (TNGX), Faeth Therapeutics (FTH), Wave Life Sciences (WVE), Kardigan (KARD), Arcus Biosciences (RCUS), Rhythm Pharmaceuticals (RYTM), Palvella Therapeutics (PVLA), Revolution Medicines (RVMD), Immunome (IMNM), Ideaya Biosciences (IDYA), Edgewise Therapeutics (EWTX), Cytokinetics (CYTK)

H.C. Wainwright — 11 calls (11 bullish, 0 bearish)

• Reiterated Buy on: Engene (ENGN), Humacyte (HUMA), ProMIS Neurosciences (PMN), Sutro Biopharma (STRO), Aquestive Therapeutics (AQST), Avalo Therapeutics (AVTX), Halozyme (HALO), Incyte (INCY), Verastem (VSTM), Opko Health (OPK); Raised PT on Nurix (NRIX)

D.A. Davidson — 9 calls (7 bullish, 2 neutral)

• Buy reiterations: Sterling Construction (STRL), Taiwan Semi (TSM), U.S. Bancorp (USB), Dick's Sporting Goods (DKS); Upgraded Martin Marietta (MLM) to Buy; Neutral reiterations: Simmons First (SFNC), First Horizon (FHN); Downgraded Varonis (VRNS) to Neutral

StoneX — 8 calls (6 bullish, 2 bearish)

• Buy reiterations: Cadence Design (CDNS), Semtech (SMTC), Abbott Labs (ABT); PT Raised: Microsoft (MSFT); PT Cuts: Equity Bancshares (EQBK), First Financial Bankshares (FFIN); Reiterated Speculative Buy: Humacyte (HUMA)

BMO Capital — 8 calls (3 bullish, 3 bearish, 2 neutral)

• Outperform reiterations: Primo Brands (PRMB), GoGold Resources (GGD); PT Raised: DTE Energy (DTE); PT Cuts: C.H. Robinson (CHRW), WEC Energy (WEC), Interactive Brokers (IBKR), Prologis (PLD), Netflix (NFLX); Lower regulatory risk note: Capella/Strategic Education

Raymond James — 8 calls (6 bullish, 0 bearish, 2 neutral)

• Strong Buy reiterations: Citizens Financial (CFG), Palvella (PVLA); Outperform reiterations: Doximity (DOCS), Progressive (PGR); Upgrades: Capri Holdings (CPRI) to Strong Buy, Brinker (EAT) to Strong Buy, Greif (GEF) to Outperform; Initiated Market Perform: Heritage Insurance (HRTG); PT Cuts: PNC Financial (PNC)

Jefferies — 8 calls (3 bullish, 5 bearish)

• PT Cuts: First Solar (FSLR), Manpower (MAN), S&P Global (SPGI), Moody's (MCO); Downgrades: FMC (FMC), Varonis (VRNS), Siemens (SIEGY); Initiated Buy: Concentra (CON); PT Raise: DT Midstream (DTM)

JPMorgan — 7 calls (3 bullish, 3 bearish, 1 neutral)

• PT Raises: ICICI Bank (IBN), Wise (WSE); Upgrades: Fomento Economico (FMX); Resumed Overweight: EchoStar (ECHO); Downgrades: Eastman Chemical (EMN), Hang Lung Properties (HLPPY); PT Cut: J.B. Hunt (JBHT); Initiated Neutral: CareTrust REIT (CTRE); Reiterated Neutral: Tesla (TSLA)

Stifel — 7 calls (6 bullish, 0 bearish, 1 mixed)

• Buy reiterations: Baker Hughes (BKR), Liberty Energy (LBRT), Glaukos (GKOS), Crescent Biopharma (CBIO), Astera Labs (ALAB), Valmont Industries (VMI); PT Raise: Chatham Lodging (CLDT); PT Cut: Semtech (SMTC)

Macquarie — 5 calls (5 bullish, 0 bearish)

• Initiated Outperform on: CACI International (CACI), FTAI Aviation (FTAI), Karman Holdings (KRMN), AeroVironment (AVAV), Kratos Defense (KTOS)

Needham — 6 calls (3 bullish, 1 bearish, 2 neutral)

• Initiated Buy: Victoria's Secret (VSXY), Boot Barn (BOOT), Urban Outfitters (URBN); Initiated Hold: Gap (GAP), Kontoor Brands (KTB); Maintained Buy: Rocket Lab (RKLB); Downgraded Varonis (VRNS) to Hold

UBS — 7 calls (3 bullish, 3 bearish, 1 neutral)

• Buy reiterations: Five Below (FIVE), Procter & Gamble (PG), Lockheed Martin (LMT); PT Raised: Five9 (FIVN), Penske Automotive (PAG); PT Cuts: American Water (AWK), WillScot (WSC), Six Flags (FUN); Neutral reiterations: Boston Beer (SAM), Apple (AAPL), Asana (ASAN)

Truist — 7 calls (5 bullish, 1 bearish, 1 neutral)

• PT Raises: Travelers (TRV), Bloom Energy (BE); Buy reiterations: Zeta Global (ZETA), Snowflake (SNOW), DigitalOcean (DOCN); Hold reiteration: J.B. Hunt (JBHT); PT Cut: DTE Energy (DTE); Downgraded CCC Intelligent Solutions (CCC) to Hold

Cantor Fitzgerald — 6 calls (4 bullish, 2 bearish)

• Overweight reiterations: CoreWeave (CRWV), Varonis (VRNS); PT Raises: Bentley Systems (BSY), Procore (PCOR), Strategy (MSTR); PT Cuts: Fidelity National (FIS), Fiserv (FISV)

Piper Sandler — 6 calls (3 bullish, 2 bearish, 1 neutral)

• PT Raises: Equity Bancshares (EQBK), Bank7 (BSVN), Opko Health (OPK), ServiceNow (NOW); PT Cut: Home Bancshares (HOMB); Downgraded Varonis (VRNS); Initiated Overweight: iRhythm (IRTC)

Keefe, Bruyette & Woods — 4 calls (1 bullish, 3 bearish)

• Outperform reiteration: Bank of New York Mellon (BNY); PT Cuts: Charles Schwab (SCHW), Prudential Financial (PRU), First Financial Bankshares (FFIN)

Citizens — 5 calls (3 bullish, 2 bearish)

• Market Outperform reiterations: Charles Schwab (SCHW), J.B. Hunt (JBHT), Opus Genetics (IRD); PT Cuts: Walker & Dunlop (WD), Rocket Lab (RKLB)

Guggenheim — 3 calls (3 bullish, 0 bearish)

• Buy reiterations: Uber (UBER), Revolution Medicines (RVMD); PT Raise: Tenet Healthcare (THC)

Bernstein SocGen — 4 calls (2 bullish, 2 bearish)

• Outperform reiterations: GE Aerospace (GE); PT Raise: Estee Lauder (EL); PT Cuts: UnitedHealth (UNH), Skydance (SKYD)

RBC Capital — 5 calls (0 bullish, 4 bearish, 1 neutral)

• PT Cuts: Kodiak Gas Services (KGS), PNC Financial (PNC), U.S. Bancorp (USB); Downgrades: Varonis (VRNS), Lloyds Banking (LYG)

TD Cowen — 3 calls (1 bullish, 1 bearish, 1 neutral)

• Buy reiteration: Coca-Cola (KO); PT Cut: PNC Financial (PNC); Downgraded Varonis (VRNS)

Morgan Stanley — 3 calls (1 bullish, 0 bearish, 2 neutral)

• PT Raise: Semtech (SMTC); Initiated Equalweight: Bandwidth (BAND) ×2 (duplicate entries)

Evercore ISI — 2 calls (2 bullish, 0 bearish)

• PT Raises: Travelers (TRV), SpaceX (SPCX)

Sector Trends

Financials — Mixed with Downward Pressure on Targets: Banks and financial services dominated the volume of calls this weekend. While reiterations of Buy/Outperform ratings were common (Citizens Financial, U.S. Bancorp, Bank of New York Mellon), price target cuts were widespread — PNC Financial received cuts from TD Cowen, RBC, and Raymond James simultaneously, while Charles Schwab saw targets trimmed by both Goldman Sachs and Keefe Bruyette. NIM (net interest margin) headwinds and valuation recalibration appear to be the common thread. The insurance sub-sector bucked the trend, with Travelers receiving multiple PT raises from Truist and Evercore ISI on strong loss ratios and earnings.

Technology & AI — Firmly Bullish, Selective Cuts: AI remained the dominant bullish theme. Microsoft's $150 PT raise, SpaceX's compute-driven upgrade, Twilio's AI agent thesis, and ServiceNow's AI growth story all reflect strong conviction in AI infrastructure and platform plays. However, not all tech was spared — Semtech saw divergent action (Stifel cut, Morgan Stanley raised, Northland upgraded, StoneX reiterated Buy), reflecting post-analyst-day volatility. Workday faced a KeyBanc downgrade on AI budget concerns, and Varonis was effectively taken off the board by six firms following its acquisition announcement.

Defense & Biotech — Broad Initiation Wave: Macquarie launched a five-stock defense sector initiation sweep (CACI, FTAI, Karman, AeroVironment, Kratos) — all at Outperform — signaling growing institutional interest in defense technology modernization. Simultaneously, William Blair initiated coverage on 12 biotech/biopharma names, all at Outperform, representing a major expansion of coverage in the clinical-stage space. These initiation clusters suggest both sectors are attracting fresh institutional attention heading into year-end.

Market Implications

The most actionable signal from this weekend's activity is the AI bifurcation story. Firms are aggressively raising targets on AI infrastructure beneficiaries (Microsoft, SpaceX, Twilio, ServiceNow, Astera Labs) while simultaneously cutting targets on companies where AI is disrupting budgets or creating competitive uncertainty (Workday downgraded by KeyBanc, Asana held at Neutral by UBS). Investors should note that "AI exposure" is no longer a monolithic bullish signal — the market is beginning to distinguish between AI enablers and AI-disrupted incumbents.

The Varonis situation is a textbook acquisition-driven consensus collapse. Six firms downgraded simultaneously to Hold/Neutral with targets clustered around $49.75, effectively signaling the stock is range-bound pending deal close. This kind of coordinated action removes near-term upside optionality and is a clear signal to rotate out of speculative positions. Meanwhile, Rocket Lab's Neutron delay to 2027 prompted Citizens to slash its target by $40, though Needham held firm at $120 — a notable divergence worth watching.

Financials present the most nuanced picture. The sector is not in distress, but analysts are clearly recalibrating expectations lower — particularly around NIM, commission headwinds (Interactive Brokers), and rate sensitivity (PNC, Schwab). The insurance sub-sector is the standout exception, with Travelers receiving broad bullish reinforcement. For investors, the message is selective: quality financial franchises with strong underwriting or fee income are preferred; rate-sensitive lenders and brokerages face continued target compression.

Key Takeaways

• 🟢 Microsoft (MSFT): StoneX raises PT to $600 from $450 — the largest dollar-magnitude raise of the weekend, driven by AI progress.
• 🔴 FMC Corp. (FMC): Jefferies cuts PT to $5 from $14 and downgrades to Hold — a 64% target reduction on pricing model shift, the steepest percentage cut of the period.
• 🔴 Varonis Systems (VRNS): Six firms downgrade simultaneously to Hold/Neutral on Proofpoint/Thoma Bravo acquisition — stock effectively capped near $49.75.
• 🟢 Costco (COST): Tigress Financial raises PT to $1,250 from $1,065 on membership growth — a $185 increase signaling continued retail resilience.
• 🔴 Skydance (SKYD): Bernstein SocGen cuts PT to $6 from $12 — 50% reduction on execution risk.
• 🟢 Bloom Energy (BE): Truist raises PT to $240 from $218 on demand growth — clean energy remains in favor.
• 🔴 Rocket Lab (RKLB): Citizens slashes PT to $90 from $130 on Neutron delay to 2027 — but Needham holds at $120, creating a notable divergence.
• 🟢 SpaceX (SPCX): Evercore ISI raises PT to $275 from $230 on compute growth — high-conviction call on the space/compute convergence theme.
• 🔴 Eastman Chemical (EMN): JPMorgan downgrades to Neutral from Overweight on commodity spread pressures.
• 🟢 Capri Holdings (CPRI): Raymond James upgrades to Strong Buy from Outperform — turnaround thesis gaining traction.
• 🔴 Workday (WDAY): KeyBanc downgrades to Sector Weight from Overweight on AI budget concerns — a meaningful shift for the HR software leader.
• 🟢 ServiceNow (NOW): Piper Sandler raises PT to $175 from $140 — 25% increase on AI growth momentum.
• 🔴 PNC Financial (PNC): Three firms (TD Cowen, RBC, Raymond James) cut price targets simultaneously — broad consensus on valuation headwinds.
• 🟢 Macquarie Defense Sweep: Five defense names (CACI, FTAI, KRMN, AVAV, KTOS) all initiated at Outperform — institutional defense sector rotation signal.
• 🟢 William Blair Biotech Blitz: 12 clinical-stage biotech names initiated at Outperform — significant expansion of coverage in the space.
• 🔴 Birkenstock (BIRK): Williams Trading downgrades to Sell from Hold on revenue concerns — rare outright Sell rating worth noting.
• 🟢 Twilio (TWLO): BTIG raises PT to $315 from $285 on AI agent opportunity.
• 🔴 Charles Schwab (SCHW): Both Goldman Sachs and Keefe Bruyette cut targets on NII/NIM outlook — double pressure on the brokerage giant.
• 🟢 Tenet Healthcare (THC): Guggenheim raises PT to $307 from $283 on momentum — healthcare services holding up well.
• 🟡 Tesla (TSLA): JPMorgan reiterates Neutral at $415 — no change in the firm's cautious stance despite ongoing market attention.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Analyst ratings can have many motivations beyond stock outlook.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/